The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis

Increased glycolysis is one of the hallmarks of cancer. The abnormal expression of glucose transporter 1 (GLUT1) was reported to be associated with resistance to current therapy and poor prognosis. Numerous studies have investigated the correlation between GLUT1 expression and prognosis in cancers,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Min, Yongzhi, Han, Chen, Shengying, Luo, Xiaodan, Lin, Ye, Zhou, Yu, Jin, Haosheng, Hou, Baohua, Deng, Yanying, Tu, Lei, Jian, Zhixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522151/
https://www.ncbi.nlm.nih.gov/pubmed/28498810
http://dx.doi.org/10.18632/oncotarget.17445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522151/
https://www.ncbi.nlm.nih.gov/pubmed/28498810
http://dx.doi.org/10.18632/oncotarget.17445

Ejemplares similares